HK1064024A1 - Combination for constructing intra-corporeal artificial kidney having function of metabolizing protein - Google Patents

Combination for constructing intra-corporeal artificial kidney having function of metabolizing protein

Info

Publication number
HK1064024A1
HK1064024A1 HK04106757A HK04106757A HK1064024A1 HK 1064024 A1 HK1064024 A1 HK 1064024A1 HK 04106757 A HK04106757 A HK 04106757A HK 04106757 A HK04106757 A HK 04106757A HK 1064024 A1 HK1064024 A1 HK 1064024A1
Authority
HK
Hong Kong
Prior art keywords
corporeal
combination
function
artificial kidney
metabolizing protein
Prior art date
Application number
HK04106757A
Other languages
English (en)
Inventor
Yasuhiko Tabata
Akihiko Saito
Fumitake Gejyo
Shigeo Furuyoshi
Kenji Yamashita
Original Assignee
Kaneka Corp
Yasuhiko Tabata
Akihiko Saito
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp, Yasuhiko Tabata, Akihiko Saito filed Critical Kaneka Corp
Publication of HK1064024A1 publication Critical patent/HK1064024A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3813—Epithelial cells, e.g. keratinocytes, urothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/26—Materials or treatment for tissue regeneration for kidney reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Vascular Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Prostheses (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
HK04106757A 2001-05-17 2004-09-07 Combination for constructing intra-corporeal artificial kidney having function of metabolizing protein HK1064024A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001147699 2001-05-17
PCT/JP2002/004778 WO2002091955A1 (fr) 2001-05-17 2002-05-17 Rein artificiel presentant la fonction de metabolisme de proteine et son procede de fabrication

Publications (1)

Publication Number Publication Date
HK1064024A1 true HK1064024A1 (en) 2005-01-21

Family

ID=18993140

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04106757A HK1064024A1 (en) 2001-05-17 2004-09-07 Combination for constructing intra-corporeal artificial kidney having function of metabolizing protein

Country Status (9)

Country Link
US (1) US20040235161A1 (xx)
EP (1) EP1388327B1 (xx)
JP (1) JP4181877B2 (xx)
KR (1) KR100864648B1 (xx)
CN (1) CN100335015C (xx)
CA (1) CA2445785C (xx)
HK (1) HK1064024A1 (xx)
TW (1) TWI221421B (xx)
WO (1) WO2002091955A1 (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094912A1 (ja) * 2004-03-31 2005-10-13 Cardio Incorporated 血管新生作用が強化された移植片
JP4752047B2 (ja) * 2004-06-30 2011-08-17 国立大学法人北海道大学 細胞培養用基材の製造方法及び細胞培養方法
JP5008284B2 (ja) * 2005-09-09 2012-08-22 グンゼ株式会社 組織再生用基材
JP4865377B2 (ja) * 2006-03-28 2012-02-01 国立大学法人 新潟大学 ヒトメガリンの測定方法
JP5166275B2 (ja) * 2006-10-17 2013-03-21 学校法人東海大学 バイオ人工尿細管
DE102007039871A1 (de) * 2007-08-21 2009-02-26 Friedrich-Baur-Gmbh Weichgewebe-Implantat mit antibakterieller Wirkung
EP2298866A4 (en) * 2008-07-02 2013-11-20 Otsuka Pharma Co Ltd ARTIFICIAL KIDNEY PRECURSOR AND METHOD FOR PRODUCING THE SAME
US8628930B2 (en) 2009-04-27 2014-01-14 Niigata University Use of megalin in urine as marker for detecting renal disorder
JP5424702B2 (ja) 2009-04-27 2014-02-26 国立大学法人 新潟大学 尿中ヒトメガリンを測定することを含む腎疾患検出方法
US9060687B2 (en) 2009-10-02 2015-06-23 Sharp Kabushiki Kaisha Device for monitoring blood vessel conditions and method for monitoring same
EP2485755A4 (en) * 2009-10-06 2014-04-02 Agency Science Tech & Res BMP-7 ADMINISTRATION AND METHODS OF USE
JP5386634B2 (ja) * 2010-03-19 2014-01-15 シャープ株式会社 測定結果処理装置、測定システム、測定結果処理方法、制御プログラムおよび記録媒体
RU2012155121A (ru) 2010-06-22 2014-07-27 ДжейДжейКей МЕДИКАЛ ЛТД. Новое средство, устройства и способы
CN105247041B (zh) * 2013-05-31 2018-04-20 爱心细胞有限公司 组入有水凝胶的层叠细胞膜片
WO2017170487A1 (ja) * 2016-03-28 2017-10-05 富士フイルム株式会社 製剤、製剤用部材およびそれらの製造方法
US20220161233A1 (en) * 2019-04-05 2022-05-26 Qidni Labs Inc. Sorbent for use in renal therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681572A (en) * 1991-10-18 1997-10-28 Seare, Jr.; William J. Porous material product and process
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US6419920B1 (en) * 1995-10-25 2002-07-16 Trans Karyotic Therapies, Inc. Hybrid matrix implants and explants
JP4023828B2 (ja) * 1996-09-05 2007-12-19 チルドレンズ・メディカル・センター・コーポレーション 人工腎臓および腎臓疾患治療へのその利用
US6277574B1 (en) * 1999-04-09 2001-08-21 Incyte Genomics, Inc. Genes associated with diseases of the kidney
MXPA02001450A (es) * 1999-10-05 2002-08-30 Transkaryotic Therapies Inc Matrices hibridas y mezclas de matriz hibridas.

Also Published As

Publication number Publication date
WO2002091955A1 (fr) 2002-11-21
CA2445785C (en) 2012-03-20
CA2445785A1 (en) 2002-11-21
JP4181877B2 (ja) 2008-11-19
US20040235161A1 (en) 2004-11-25
EP1388327A1 (en) 2004-02-11
EP1388327A4 (en) 2009-08-19
TWI221421B (en) 2004-10-01
CN100335015C (zh) 2007-09-05
KR100864648B1 (ko) 2008-10-23
JPWO2002091955A1 (ja) 2004-08-26
CN1509155A (zh) 2004-06-30
EP1388327B1 (en) 2012-02-22
KR20040004621A (ko) 2004-01-13

Similar Documents

Publication Publication Date Title
HK1064024A1 (en) Combination for constructing intra-corporeal artificial kidney having function of metabolizing protein
HUP0402162A3 (en) Specific binding agents of human angiopoietin-2
AU8116601A (en) Implantable joint prosthesis
IL212419A0 (en) Methods of administering anti-tnf antibodies
EP1379264A4 (en) HUMAN SECRETED PROTEINS
TW549074U (en) Artificial knee joint
IL160998A0 (en) Human tissue factor antibodies
EP1385380A4 (en) PROTEINS SECRETED BY MAN
AU2002324965A1 (en) Artificial kidney and methods of using same
IL160723A0 (en) Methods of kidney transplantation utilizing developing nephric tissue
GB0218205D0 (en) Human ZZAP1 protein
GB0108863D0 (en) Combinational therapy
EP1452597A4 (en) PROTEIN ACTIVATION METHOD
AU4157002A (en) Novel human proteins, polynucleotides encoding them and methods of using the same
EP1578906A4 (en) AFAP SEQUENCES, POLYPEPTIDES, ANTIBODIES AND METHODS
HU0101713D0 (en) Process for the preparation of artificial blood
IL218961A0 (en) Methods of kidney transplantation utilizing developing nephric tissue
AU2002353431A8 (en) Method of modification of a protein or polypeptide
GB0105902D0 (en) Artificial tissue using foams
AU2002364705A8 (en) Antisense modulation of protein expression
GB0130560D0 (en) Proteins
AU2002242870A1 (en) Nucleic acids encoding human est1 proteins
GB0125867D0 (en) Isolation of protein
GB0127782D0 (en) Mimic walking blood pump
ZA200402394B (en) Specific binding agents of human angiopoietin-2.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200517